5-Diethylaminomethyl-4-methyl-thiophene-2-carboxylic acid → 4-[5-(5-Diethylaminomethyl-4-methyl-thiophen-2-yl)-[1,2,4]oxadiazol-3-yl]-2-methoxy-6-methyl-phenol
반응식
[CH2:1]([N:3]([CH2:6][C:7]1[S:11][C:10]([C:12]([OH:14])=O)=[CH:9][C:8]=1[CH3:15])[CH2:4][CH3:5])[CH3:2].[OH:16][C:17]1[C:26]([CH3:27])=[CH:25][C:20]([C:21]([NH:23]O)=[NH:22])=[CH:19][C:18]=1[O:28][CH3:29]>>[CH2:4]([N:3]([CH2:6][C:7]1[S:11][C:10]([C:12]2[O:14][N:23]=[C:21]([C:20]3[CH:25]=[C:26]([CH3:27])[C:17]([OH:16])=[C:18]([O:28][CH3:29])[CH:19]=3)[N:22]=2)=[CH:9][C:8]=1[CH3:15])[CH2:1][CH3:2])[CH3:5]참가 물질
3
실험 절차
The title compound (16 mg) is prepared starting from 5-diethylaminomethyl-4-methyl-thiophene-2-carboxylic acid (30 mg, 130 μmol) and 4,N-dihydroxy-3-methoxy-5-methyl-benzamidine (23 mg, 117 μmol) according to Method A; LC-MS: tR=0.57 min; [M+1]+=387.78.
출처 및 근거
- ORD 기록
- ord-e4264427fc1540cd8837a4f1cedecec5
- 출처 데이터셋
- uspto-grants-2012_04
- DOI